Evidence map›Paper›PMID 41995898›Full record

ArticleTheory in biosciences = Theorie in den Biowissenschaften2026

RNA-templated diversity generation via reverse transcription and homologous recombination: an evolutionary hypothesis.

Matteo G E Mariani

Abstract read
PubMed Publisher
In one paragraph

Article in Theory in biosciences = Theorie in den Biowissenschaften, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Matteo G E Mariani, Loc. Cerreto N.1, 62032, Camerino, Italy. mgemariani@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is commonly believed that organisms diversify their genomes primarily through point mutations, insertions, and deletions. Here, I propose a complementary mechanism: Diversity Generation by Reverse Transcriptase (DGbyRT), in which cellular or exogenous RNAs are reverse transcribed into cDNA and integrated into the genome via homology-directed recombination. This process enables the reuse of modular genetic information-derived from both coding and non-coding transcripts-thereby biasing variation toward regions already represented in the transcriptome and potentially altering the statistical distribution of the explored sequence space. DGbyRT draws on mechanisms observed across life, including diversity-generating retroelements, retrotransposons, telomerase, and somatic hypermutation, and may involve endogenous RTs such as Pol-θ. I hypothesise that transcribed pseudogenes and duplicated sequences may serve as reservoirs for recombinable modules. DGbyRT may also contribute to somatic-to-germline communication, with reverse-transcribed RNAs crossing the Weismann barrier to influence heritable change. Inspired by synthetic biology tools such as the AutoDiMe method, DGbyRT is presented as a context-dependent diversification mechanism whose frequency may be modulated by cellular regulation of reverse transcriptase activity. As RNA-based technologies advance, understanding natural reverse transcription becomes increasingly relevant to both evolutionary biology and therapeutic innovation.

Indexed as

Evolution, MolecularGenetic VariationHomologous RecombinationReverse TranscriptionRNAAnimalsDNA, ComplementaryGenomeHumansModels, GeneticMutationPseudogenesRetroelementsRNA-Directed DNA PolymeraseTelomeraseDNA, ComplementaryRetroelementsRNARNA-Directed DNA PolymeraseTelomeraseGenome evolutionGenomic diversificationHomologous recombinationMutation mechanismsPseudogenesReverse transcription

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.